NEU 0.00% $17.09 neuren pharmaceuticals limited

I think Acadia were probably trying to capitalise on Neuren's SP...

  1. 388 Posts.
    lightbulb Created with Sketch. 243
    I think Acadia were probably trying to capitalise on Neuren's SP hammering and hoping they could wrap up the ROW on the cheap. I still think Acadia will be the partner, but Neuren are right to test the market value of the offering. It's the only way to push Acadia to dig deeper.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.